Utama › Kanser Paru-paru Bukan Sel Kecil › Delaware

Kajian klinikal Kanser Paru-paru Bukan Sel Kecil di Delaware

21 kajian untuk Kanser Paru-paru Bukan Sel Kecil sedang mencari peserta di lokasi di Delaware.

Bandar di Delaware

Teks kajian rasmi (Bahasa Inggeris)

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Beebe South Coastal Health Campus, Millville
Helen F Graham Cancer Center, Newark
Medical Oncology Hematology Consultants PA, Newark
dan 1 lagi

Mengambil pesertaFasa 3

Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT04267848

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Medical Oncology Hematology Consultants, Newark

Mengambil pesertaFasa 1/2

Umur 12 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT04585750

Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial

Beebe South Coastal Health Campus, Millville
Helen F Graham Cancer Center, Newark
Medical Oncology Hematology Consultants PA, Newark
dan 1 lagi

Mengambil pesertaFasa 3

Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT07388524

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Beebe South Coastal Health Campus, Millville
Helen F Graham Cancer Center, Newark
Medical Oncology Hematology Consultants PA, Newark
dan 1 lagi

Mengambil pesertaFasa 3

Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06498635

A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)

Medical Oncology Hematology Consultants, PA, Newark

Mengambil pesertaFasa 3

Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT07361497

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

Medical Oncology Hematology Consultants, PA, Newark

Mengambil pesertaFasa 3

Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07144280

A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)

Medical Oncology Hematology Consultants Helen F Graham Cancer Center, Newark

Mengambil pesertaFasa 3

Umur 18 hingga 100 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT05920356

A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

ChristianaCare Helen F Graham Cancer Center and Research Institute, Newark

Mengambil pesertaFasa 2

Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06667076

A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

ChristianaCare Health System, Newark

Mengambil pesertaFasa 2

Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07154290

A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer

Research Site, Newark

Mengambil pesertaFasa 3

Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06868277

Prospective External Control Cohort In Patients With Newly Diagnosed Advanced or Metastatic EGFR Mutant Non-Small Cell Lung Cancer

Bayhealth Cancer Center- Kent, Dover
Bayhealth Cancer Center- Sussex, Milford

Mengambil pesertaKajian pemerhatian

Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07028489

An External Control Arm Study in Non-Small Cell Lung Cancer

Bayhealth Medical Center, Kent Campus, Dover
Bayhealth Medical Center- Sussex Campus, Milford

Mengambil pesertaKajian pemerhatian

Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07174388

A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)

Medical Oncology Hematology Consultants, PA, Newark

Mengambil pesertaFasa 3

Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT06875310

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

Research Site, Newark

Mengambil pesertaFasa 3

Umur 18 ke atas · Semua jantina · Dikemas kini 18 Sep 2026 · NCT06692738

Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations

Research Site, Newark

Mengambil pesertaFasa 3

Umur 18 ke atas · Semua jantina · Dikemas kini 4 Sep 2026 · NCT07291037

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Bayhealth Hospital Kent Campus, Dover
Bayhealth Hospital Sussex Campus, Milford

Mengambil pesertaFasa 2

Umur 18 ke atas · Semua jantina · Dikemas kini 3 Jun 2026 · NCT05642572

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

Bayhealth Hospital Kent Campus, Dover
Bayhealth Hospital Sussex Campus, Milford

Mengambil pesertaFasa 2

Umur 18 ke atas · Semua jantina · Dikemas kini 6 Mei 2026 · NCT06116682

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

Bayhealth Hospital Kent Campus, Dover
Bayhealth Hospital Sussex Campus, Milford

Mengambil pesertaFasa 2

18 Minutes · Semua jantina · Dikemas kini 5 Mei 2026 · NCT06031688

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

Beebe South Coastal Health Campus, Millville
Helen F Graham Cancer Center, Newark
Medical Oncology Hematology Consultants PA, Newark
dan 1 lagi

Mengambil pesertaFasa 2/3

Umur 18 ke atas · Semua jantina · Dikemas kini 5 Mei 2026 · NCT06616584

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Beebe South Coastal Health Campus, Millville
Helen F Graham Cancer Center, Newark
Medical Oncology Hematology Consultants PA, Newark
dan 1 lagi

Mengambil pesertaKajian pemerhatian

Umur 18 ke atas · Semua jantina · Dikemas kini 17 Mac 2026 · NCT06418204

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Massive Bio SYNERGY-AI site, Newark

Mengambil pesertaKajian pemerhatian

Semua umur · Semua jantina · Dikemas kini 28 Okt 2025 · NCT03452774

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.